InvestorsHub Logo
Followers 24
Posts 5031
Boards Moderated 0
Alias Born 09/27/2005

Re: gfp927z post# 18781

Monday, 03/08/2021 9:46:58 AM

Monday, March 08, 2021 9:46:58 AM

Post# of 19856
24% is better than nothing, but now they're going to have to do another trial "enrolling 140 critically ill COVID-19 patients with the primary endpoint defined as length of hospital stay." They're changing the primary endpoint.
So, probably no EUA in the near future. The new trial will likely take 3-5 months. Meanwhile, they'll try to sell leronlimab in some other country. Basically, the trial failed to meet its primary endpoint, they're going after only critically ill patients now, not including severe, I don't see any immediate catalyst for the stock.
The share price usually bombs after conference calls. They're holding one today at 4:00 eastern. Looks like a rough week.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.